Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Parazero Technologies Ltd. Ordinary Shares
ParaZero Announces First Half of 2025 Financial Results
Business
Aug 28 2025
12 min read

ParaZero Announces First Half of 2025 Financial Results

news images

Sales increased by approximately 27% compared to the same period in 2024

KFAR SABA, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, reported today its financial results for the six months ended June 30, 2025.

Key Highlights of ParaZero’s Achievements in the First Half of 2025 & Recent Updates:

Financial and Corporate Updates:

  • Sales increased by 26.6% to $357,979 for the six months ended June 30, 2025.

  • ParaZero raised approximately $3.1 million and $2.2 million in gross proceeds from registered direct offerings in February 2025 and August 2025, respectively

  • Appointed Ariel Alon, a senior UAV executive, as company's CEO.

Counter-Drone Systems:

  • ParaZero bolstered its counter-drone technology with approval from the Israeli Defense Export Controls Agency (DECA) under the Israeli Ministry of Defense approval to market DefendAir globally, targeting a high-growth market.

  • Showcased DefendAir Hand-Held Net Launcher in two field tests with a select group of Israeli security and defense professionals, each demonstrating a 100% interception success rate, effectively neutralizing every fast-incoming multirotor drone threat in real-time scenarios.

  • Conducted several field trials of updated configurations to provide solutions to different evolving drone threat scenarios, at the discretion of defense entities, which further strengthened its market position. The company quickly reshaped its strategy, technology, and IP assets to address one of the world's biggest commercial, homeland security, and defense challenges: the threats posed by drones.

Airdrop Systems:

  • Enhanced its portfolio with successful DropAir precise airdrop system tests for critical supply delivery. Integrated with military and several commercial drones, DropAir enabled rapid autonomous and accurate supply through drones in the most challenging terrains in general, and the supplement of blood transfusions in combat specifically, as shown in a defense demo.

  • Progressed to Phase II with the Israeli Ministry of Defense, focusing on delivering pilot systems for implementation and additional operational testing in various scenarios.

  • Secured global marketing approvals from DECA under the Israeli Ministry of Defense for collaborations with Heven Drones and Stedicopter after full integration with their platforms.

Ariel Alon, CEO of ParaZero, commented: "As the newly appointed CEO of ParaZero Technologies, I am thrilled to lead a company with such immense potential in the rapidly growing counter-drone and defense markets. We believe that our recent successes, including securing approvals from DECA under the Israeli Ministry of Defense for the global marketing of our DefendAir counter-UAS system and achieving a 100% interception rate in live field demonstrations, position us well at the forefront of a market projected to grow from USD 3.10 billion in 2025 to USD 12.24 billion by 2032, with a CAGR of 21.62%. Our advancements in precision airdrop systems like DropAir, coupled with our strategic partnerships, demonstrate our capability to deliver cutting-edge solutions. I see tremendous potential opportunities to drive innovation and capture market share in this dynamic, high-growth sector."

First Half 2025 Financial Highlights:

  • Sales totaled to $357,979 for the six months ended June 30, 2025, compared to $282,693 for the six months ended June 30, 2024. This increase was mainly attributed to the company shifting towards sales of newly developed products, mainly in the defense sector, and original equipment manufacturer integrations that contributed to a higher volume of sales rather than to the aftermarket segment.

  • Cost of sales amounted to $431,888 for the six months ended June 30, 2025, compared to $209,529 for the six months ended June 30, 2024. The increase was mainly due to the increase in the volume of sales and product mix during the six months ended June 30, 2025, an inventory write-off and higher overhead costs and personnel related to the new lease for our corporate offices and headquarters.

  • Research and development expenses for the six months ended June 30, 2025, amounted to $1,155,436, compared to $662,440 for the six months ended June 30, 2024. The increase resulted mainly from labor costs due to the increased number of employees and contractors’ costs.

  • Selling and marketing expenses totaled $752,420 for the six months ended June 30, 2025, compared to $516,401 for the six months ended June 30, 2024. The increase resulted mainly from labor costs and marketing services, accompanied by an increase in travel and conferences participation costs.

  • General and administrative expenses totaled $1,670,513 for the six months ended June 30, 2025, compared to $1,122,759 for the six months ended June 30, 2024. The increase resulted mainly from non-cash expenses related to grants pursuant to our equity incentive plan and certain filing services.

  • Comprehensive and net loss amounted to $2,295,955 for the six months ended June 30, 2025, compared to a net loss of $2,026,094 for the six months ended June 30, 2024. The increase was the result of changes in fair value of derivative warrant liabilities, along with an increase in expenses related to grants pursuant to our equity incentive plan along with an increase of operating expenses, as described above.

  • Net loss per share for the six months of 2025 was $0.14 compared to net loss per share of $0.19 for the six months ended June 30, 2024.

  • As of June 30, 2025, the Company’s cash, cash equivalents and short-term deposits were $4.86 million and approximately $6.2 million  as of August 27, 2025.

About ParaZero Technologies

ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry. Founded in 2014 by aviation professionals and drone industry veterans, ParaZero is a recognized leader in advanced drone technologies, supporting commercial, industrial, and governmental operations worldwide. The company’s product portfolio includes SafeAir, an autonomous parachute recovery system designed for aerial safety and regulatory compliance; DefendAir, a counter-UAS net-launching platform for protection against hostile drones in both battlefield and urban environments; and DropAir, a precision aerial delivery system. ParaZero’s mission is to redefine the boundaries of aerial operations with intelligent, mission-ready systems that enhance safety, scalability, and security. For more information, visit https://parazero.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, ParaZero is using forward-looking statements when it discusses the potential of the company, the rapidly growing counter-drone and defense markets, it belief that its recent successes position it to be at the forefront of the growth in the global anti-drone market and its potential opportunities to drive innovation and capture market share. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s Annual Report on Form 20-F filed with the SEC on March 21, 2025. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. ParaZero is not responsible for the content of third-party websites.

Investor Relations Contact:

Michal Efraty
Investor Relations
michal@efraty.com


ParaZero Technologies Ltd.

BALANCE SHEET

(U.S. dollars in thousands, except share data and per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30,

 

 

December 31,

 

 

 

Note

 

2025

 

 

2024

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

2,365,582

 

 

 

4,178,866

 

Short term deposits

 

 

 

 

2,500,000

 

 

 

 

Trade receivables

 

 

 

 

36,675

 

 

 

114,564

 

Other current assets

 

3

 

 

550,044

 

 

 

421,919

 

Inventories

 

 

 

 

340,461

 

 

 

394,193

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL CURRENT ASSETS

 

 

 

 

5,792,762

 

 

 

5,109,542

 

 

 

 

 

 

 

 

 

 

 

 

NON-CURRENT ASSETS:

 

 

 

 

 

 

 

 

 

 

Restricted deposit

 

4

 

 

76,364

 

 

 

68,001

 

Prepaid expenses

 

 

 

 

15,728

 

 

 

33,333

 

Operating lease right-of-use asset

 

5

 

 

332,449

 

 

 

418,790

 

Property and equipment, net

 

 

 

 

114,962

 

 

 

107,906

 

TOTAL NON-CURRENT ASSETS

 

 

 

 

539,503

 

 

 

628,030

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

 

 

 

6,332,265

 

 

 

5,737,572

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

(U.S. dollars in thousands, except share data and per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30,

 

 

December 31,

 

 

 

Note

 

2025

 

 

2024

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

 

Trade payables

 

 

 

 

182,322

 

 

 

184,247

 

Operating lease liabilities

 

5

 

 

218,985

 

 

 

202,563

 

Other current liabilities

 

6

 

 

835,830

 

 

 

933,995

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL CURRENT LIABILITIES

 

 

 

 

1,237,137

 

 

 

1,320,805

 

 

 

 

 

 

 

 

 

 

 

 

NON-CURRENT LIABILITIES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating lease liabilities, net of current portion

 

5

 

 

141,169

 

 

 

216,917

 

Derivative warrant liabilities

 

7

 

 

1,424,033

 

 

 

4,511,491

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL NON-CURRENT LIABILITIES

 

 

 

 

1,565,202

 

 

 

4,728,408

 

 

 

 

 

 

 

 

 

 

 

 

COMMITMENTS AND CONTINGENCIES

 

9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SHAREHOLDERS’ DEFICIT

 

8

 

 

 

 

 

 

 

 

Ordinary shares, NIS 0.02 par value: Authorized 200,000,000 as of June 30, 2025 and December 31, 2024; Issued and outstanding 17,063,630 and 12,817,092 shares as of June 30, 2025 and as of December 31, 2024, respectively

 

 

 

 

95,782

 

 

 

72,061

 

Additional paid-in capital

 

 

 

 

35,207,386

 

 

 

29,093,585

 

Accumulated losses

 

 

 

 

(31,773,242

)

 

 

(29,477,287

)

 

 

 

 

 

 

 

 

 

 

 

TOTAL SHAREHOLDERS’ EQUITY

 

 

 

 

3,529,926

 

 

 

(311,641

)

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

6,332,265

 

 

 

5,737,572

 

 

 

 

 

 

 

 

 

 

 

 


STATEMENTS OF COMPREHENSIVE LOSS

(U.S. dollars in thousands, except share data and per share data)

 

 

 

 

 

 

 

 

 

Six months ended
June 30,

 

 

Six months ended
June 30,

 

 

 

2025

 

 

2024

 

 

 

U.S. dollars

 

 

 

 

 

 

 

 

Sales

 

 

357,979

 

 

 

282,693

 

Cost of Sales

 

 

431,888

 

 

 

209,529

 

 

 

 

 

 

 

 

 

 

GROSS PROFIT (LOSS)

 

 

(73,909

)

 

 

73,164

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

 

1,155,436

 

 

 

662,440

 

Selling and marketing expenses

 

 

752,420

 

 

 

516,401

 

General and administrative expenses

 

 

1,670,513

 

 

 

1,122,759

 

 

 

 

 

 

 

 

 

 

OPERATING LOSS

 

 

(3,652,278

)

 

 

(2,228,436

)

Change in fair value of derivative warrant liabilities

 

 

1,253,042

 

 

 

67,227

 

Other finance income, net

 

 

103,281

 

 

 

135,115

 

 

 

 

 

 

 

 

 

 

NET LOSS AND COMPREHENSIVE LOSS

 

 

(2,295,955

)

 

 

(2,026,094

)

 

 

 

 

 

 

 

 

 

Net loss per ordinary share, basic and diluted

 

 

(0.14

)

 

 

(0.19

)

Weighted average number of ordinary shares outstanding, basic and diluted

 

 

16,018,334

 

 

 

10,940,958

 

 

 

 

 

 

 

 

 

 


STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)

(U.S. dollars in thousands, except share data and per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ordinary shares

 

 

Additional

 

 

 

 

 

 

 

 

 

Number

 

 

 

 

 

paid-in

 

 

Accumulated

 

 

 

 

 

 

of shares

 

 

Amount

 

 

capital

 

 

losses

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BALANCE AS OF DECEMBER 31, 2023

 

 

10,073,956

 

 

 

56,227

 

 

 

24,471,888

 

 

 

(18,423,057

)

 

 

6,105,058

 

CHANGES DURING THE SIX MONTHS ENDED JUNE 30, 2024:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock based compensation

 

 

-

 

 

 

-

 

 

 

26,434

 

 

 

-

 

 

 

26,434

 

Exercise of pre-funded warrants and consultant warrants (Note 8B)

 

 

1,088,590

 

 

 

5,792

 

 

 

(5,792

)

 

 

-

 

 

 

-

 

Comprehensive loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,026,094

)

 

 

(2,026,094

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BALANCE AS OF JUNE 30, 2024

 

 

11,162,546

 

 

 

62,019

 

 

 

24,492,530

 

 

 

(20,449,151

)

 

 

4,105,398

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BALANCE AS OF DECEMBER 31, 2024

 

 

12,817,092

 

 

 

72,061

 

 

 

29,093,585

 

 

 

(29,477,287

)

 

 

(311,641

)

CHANGES DURING SIX MONTHS ENDED JUNE 30, 2025:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of ordinary shares and pre-funded warrants, net of issuance costs (Note 8D)

 

 

2,818,182

 

 

 

15,762

 

 

 

2,516,733

 

 

 

 

 

 

 

2,532,495

 

Stock based compensation

 

 

 

 

 

 

 

 

 

 

511,818

 

 

 

 

 

 

 

511,818

 

Issuance of ordinary shares from vested restricted share units

 

 

283,999

 

 

 

1,611

 

 

 

(1,611

)

 

 

 

 

 

 

-

 

Exercise of series A warrants (Note 8B)

 

 

1,144,357

 

 

 

6,348

 

 

 

3,086,861

 

 

 

 

 

 

 

3,093,209

 

Comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,295,955

)

 

 

(2,295,955

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BALANCE AS OF JUNE 30, 2025

 

 

17,063,630

 

 

 

95,782

 

 

 

35,207,386

 

 

 

(31,773,242

)

 

 

3,529,926

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


STATEMENTS OF CASH FLOWS

(U.S. dollars in thousands, except share data and per share data)

 

 

 

 

 

 

Six months ended
June 30,

 

 

 

2025

 

 

2024

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

Net loss

 

 

(2,295,955

)

 

 

(2,026,094

)

 

 

 

 

 

 

 

 

 

Adjustments required to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation

 

 

13,762

 

 

 

10,448

 

Stock based compensation

 

 

511,818

 

 

 

26,434

 

Inventory write-down

 

 

81,677

 

 

 

 

Changes in fair value of derivative liabilities

 

 

(1,253,042

)

 

 

(67,227

)

Loss from exchange differences on cash and cash equivalents

 

 

5,640

 

 

 

2,850

 

Finance (expenses) income

 

 

27,015

 

 

 

(14,104

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Trade receivables, net

 

 

77,889

 

 

 

(89,622

)

Other current assets

 

 

(128,125

)

 

 

(34,221

)

Prepaid expenses

 

 

17,605

 

 

 

 

Inventories

 

 

(27,945

)

 

 

(113,261

)

Operating lease right-of use asset

 

 

86,341

 

 

 

53,863

 

Trade payables

 

 

(1,925

)

 

 

134,346

 

Operating lease liabilities

 

 

(86,341

)

 

 

(53,279

)

Other current liabilities

 

 

(98,165

)

 

 

166,386

 

 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

 

(3,069,751

)

 

 

(2,003,481

)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment in short term deposits

 

 

(2,500,000

)

 

 

 

Change in restricted deposit

 

 

(8,363

)

 

 

(68,603

)

Purchase of property and equipment

 

 

(20,818

)

 

 

(64,366

)

Net cash used in investing activities

 

 

(2,529,181

)

 

 

(132,969

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from exercise of series A warrants (Note 8B)

 

 

1,258,793

 

 

 

 

Issuance of ordinary shares and prefunded warrants, net of issuance costs (Note 8D)

 

 

2,532,495

 

 

 

 

Net cash from financing activities

 

 

3,791,288

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash, cash equivalents

 

 

(5,640

)

 

 

(2,850

)

Net decrease in cash and cash equivalents

 

 

(1,813,284

)

 

 

(2,139,300

)

Cash and cash equivalents at beginning of period

 

 

4,178,866

 

 

 

7,428,405

 

Cash and cash equivalents at end of period

 

 

2,365,582

 

 

 

5,289,105